FDA Rejects Savient's Gout Drug - New York Times
FDA Rejects Savient's Gout DrugNew York TimesSavient, based in East Brunswick, NJ, said it hoped it could resubmit its application for approval of the drug, called Krystexxa, early next year. ...Savient says FDA not approved gout drug; to resubmitReutersall 32 news articles��
No comments:
Post a Comment